Gabelli Funds’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Gabelli Funds’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-279,105	Closed	-$5.84M	–	1189
2016 Q3	$5.84M	Buy	+279,105	New	+$3.21M	0.03%	508

Gabelli Funds's VTAE Position: Q4 2016 in Review

Gabelli Funds sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 279,105 shares — an estimated $5.84M sold.

Gabelli Funds first reported a position in VTAE in Q3 2016 and held it in 1 quarter. The position peaked at $5.84M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Gabelli Funds reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Gabelli Funds sold 279,105 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $5.84M.
Gabelli Funds first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2016 and held it in 1 quarter.
Gabelli Funds's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $5.84M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Gabelli Funds's 13F filing for Q4 2016, filed 10 Feb 2017.